Skip to main content

South Africa Launches clinical trial of BCG Vaccine against new Coronavirus

South Africa Launches clinical trial of BCG vaccine against new Coronavirus

A research institute in South Africa vaccinated hundreds of medical personnel on the 4th with BCG vaccine to explore whether this commonly used vaccine to prevent tuberculosis can be used to prevent new coronary pneumonia.

 

South African Research on Coronavirus

This clinical trial was conducted at the Tiger Berg Hospital in Cape Town. The project is a clinical research institution called TASK.

In a statement, TASK stated that they have vaccinated BCG for 250 medical staff and injected a placebo for another 250 medical staff.


Whether BCG can reduce risk of Coonavirus

BCG, which came out in 1921, is a widely-vaccinated anti-tuberculosis vaccine.

The TASK researchers said they hope that this trial will understand whether BCG can reduce the risk of new coronary pneumonia infection or reduce related symptoms.

 

According to media reports, the Netherlands, Australia and other countries are also carrying out similar clinical trial projects.

 

 

Comments

Popular posts from this blog

Difference Between COVID-19 Coronavirus and Other Flu Epidemic Infections

What are the differences between COVID-19 and the flu epidemic?The epidemic caused by the new Coronavirus (2019-nCoV) is still spreading. This disease, which has just been officially named COVID-19, has caused more than 40,000 infections and more than 1,000 deaths. At the same time, on the other side of the ocean, another epidemic also attracted people's attention. The flu season in the United States is on schedule. 
According to data released by the US Centers for Disease Control and Prevention, as of February 1, 22 million to 31 million people are expected to be infected during the flu season, and the number of patients dying from influenza is between 12,000 and 30,000. 
Seeing such figures, some readers may be surprised when they think: Is the flu epidemic in the United States worse? What are the differences between COVID-19 and the flu epidemic? Is this really the case? What are the differences between COVID-19 and the flu epidemic?
The facts are being unraveled below: 1. Unknown ris…

FDA Launches New Website to Encourage COVID-19 Rehabilitation Patients to Donate Plasma

According to foreign media TechCrunch, one of the ways currently being sought to develop effective treatments for COVID-19 is to use convalescent plasma. Basically, this means using plasma from COVID-19 patients who have fully recovered, hoping to transfer the antibodies they produced during the fight against the virus to others. 

US Food and Drug Administration (FDA) creates dedicated website to seek recovery plasma donationsThe US Food and Drug Administration (FDA) has created a dedicated new website that seeks recovery plasma donations from COVID-19 rehabilitation patients and explains their potential uses.
The use of plasma during recovery is hardly a new concept. In fact, it has been used since the late 1890s and was used during the Spanish influenza pandemic in 1918, although "the results were mixed."
Modern methods can help improve the efficacy and potential of recovered plasma as a therapeutic method. There are currently some drugs under development that use plasma (ani…

Considerations Before Electrocardiogram ECG Test